...
首页> 外文期刊>Water Research >Peracetic acid (PAA) and low-pressure ultraviolet (LP-UV) inactivation of Coxsackievirus B3 (CVB3) in municipal wastewater individually and concurrently
【24h】

Peracetic acid (PAA) and low-pressure ultraviolet (LP-UV) inactivation of Coxsackievirus B3 (CVB3) in municipal wastewater individually and concurrently

机译:过乙酸(PAA)和低压紫外线(LP-UV)单独和同时在市政废水中灭活COXSackeigirus B3(CVB3)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Domestic wastewater (WW) contains a large number of pathogenic viruses that are not significantly reduced in most WW treatment processes and are found in high numbers in the effluent of conventionally disinfected WW. In this study, secondary WW effluent bench-scale disinfection efficacy experiments with two different peracetic acid (PAA) formulations (15 and 22% peracetic acid) and lowpressure ultraviolet irradiation (LP-UV) were carried out using Coxsackievirus B3 (CVB3) as a clinically relevant surrogate for enteric viruses and Escherichia coli (E. coli) as the disinfection efficacy control. Efficacy experiments were done in a test matrix of medium-pressure UV (MP-UV) decontaminated secondary WW effluent under representative PAA doses and LP-UV fluences used at wastewater treatment plants (WWTP). Membrane filtration technique was used to determine Log(10) CFU reductions of E. coli and a tissue culture infectious dose 50% assay (TCID50) for Logio TCID50 reduction of CVB3. The CVB3 proved to be quite resistant to PAA with 1 Log(10) TCID50 reduction to concentrations = 50 mg/L at a contact time of 15 min, and highly susceptible to LP-UV at 20 mJ/cm(2). Concurrent use of both formulations of 3 mg/L PAA with 20 mJ/cm(2) LP-UV achieved -4 Log(10) TCID50 reduction. The E. coli results showed 5 Log(10) CFU reductions at a contact time of 15 min with both 3 mg/L PAA formulations, 20 mJ/cm(2) LP-UV treatment alone, and combined with both 1.5 mg/L PAA formulations. The E. coli efficacy data were consistent with that reported in the literature and showed to be comparable to conventional chlorine disinfection. The CVB3 efficacy data has shown that PAA alone may not be suitable for the reduction of enteric viruses in secondary wastewater effluent, but this is also the case for chlorine-based disinfectants. The results from this study showed that the use of PAA with LP-UV at reasonable concentrations (1.5 mg/L) and fluence (20 mJ/cm(2)) can significantly reduce the PAA use and meet wastewater disinfection goals for both E. coli and CVs. However, the concurrent use of PAA with LP-UV did not lead to significant synergy in disinfection efficacy in wastewater. (C) 2020 Elsevier Ltd. All rights reserved.
机译:国内废水(WW)含有大量致病病毒,在大多数WW治疗过程中没有显着降低,并且在常规消毒WW的流出物中被发现在高位。在该研究中,使用CoxSackeivirus B3(CVB3)作为a,用两种不同的过乙酸(PAA)制剂(15和22%过乙酸)和低压紫外线辐射(LP-UV)进行二次WW流出物的二级消毒功效实验肠道病毒和大肠杆菌(大肠杆菌)的临床相关替代物作为消毒功效控制。在代表性Paa剂量和废水处理厂(WWTP)中使用的代表性PAA剂量和LP-UV流量的中压UV(MP-UV)净化的二级流出物的测试基质中进行了功效实验。用于测定大肠杆菌和组织培养剂量50%测定(TCID50)的LOGIO TCID50减少CVB3的LOGIO TCID50减少的膜过滤技术。 CVB3证明对PAA的耐受<1 log(10)TCID50的浓度与15分钟的接触时间浓度<= 50mg / L的浓度,并且高易受20mJ / cm(2)的LP-UV。同时使用3mg / L Paa的配方,具有20mJ / cm(2)LP-UV达到-4 log(10)TCID50减少。大肠杆菌结果显示> 5对数(10)CFU在15分钟的接触时间下减少3mg / L PAA配方,20mJ / cm(2)LP-UV处理,并与1.5mg / l paa配方。大肠杆菌疗效数据与文献中报道的那一致,并且显示与常规氯消毒相当。 CVB3疗效数据表明,单独的PAA可能不适合减少二次废水流出物中的肠溶病毒,但也是氯的消毒剂的情况也是如此。本研究的结果表明,在合理浓度(1.5mg / L)和注量(20mJ / cm(2))可以显着降低PAA使用,并满足e的废水消毒目标,使用PAA。 Coli和CVS。然而,PAA与LP-UV的同时使用不会导致废水中消毒功效的显着协同作用。 (c)2020 elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号